Role of apoptosis and apoptosis-related proteins in the cisplatin-resistant phenotype of human tumor cell lines

被引:52
作者
Perego, P
Righetti, SC
Supino, R
Delia, D
Caserini, C
Carenini, N
Bedogne, B
Broome, E
Krajewski, S
Reed, JC
Zunino, F
机构
[1] Ist Nazl Studio & Cura Tumori, Div Expt Oncol B, I-20133 Milan, Italy
[2] Ist Nazl Studio & Cura Tumori, Div Expt Oncol A, I-20133 Milan, Italy
[3] Univ Calif San Diego, San Diego, CA 92103 USA
[4] Burnham Inst, La Jolla, CA 92037 USA
基金
美国国家卫生研究院;
关键词
apoptosis; bcl-2; cisplatin resistance; p53;
D O I
10.1023/A:1026442716000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since apoptosis is the primary made of cell death induced by cisplatin, the role of apoptosis acid apoptosis-related gene products in cisplatin resistance was Investigated in four human cisplatin-resistant cell lines of different tumour type. A common feature of the resistant sublines was a reduced susceptibility to drug-induced apoptosis compared to parental sensitive lines. Loss of wild-type p53 function was not a general event associated with the development of drug resistance. an increased bcl-2 expression was found in resistant cells characterized by mutant p53 (A431/Pt and IGROV-1?/Pt), whereas in osteosarcoma (U2-PS/Pt) and in ovarian carcinoma (A2780/CP) cells with wildtype p53, bcl-2 levels were markedly reduced. U2-OS/Pt cells had a 16-fold increase In the level of Bcl-x(L) protein, Stable transfection of CIP-CIS cells with bcl-x(L) cDNA conferred a low Level of drug resistance io cisplatin, suggesting that overexpression of this gene contributes to the cisplatin-resistant phenotype of this osteosarcoma cell system. in conclusion, these observations suggest a variable contribution of apoptosis-related genes to cisplatin resistance depending on the biological background of the cell system and presumably reflecting different pathways of apoptosis.
引用
收藏
页码:540 / 548
页数:9
相关论文
共 40 条
[1]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[2]   BCL-X(L) AND BCL-2 REPRESS A COMMON PATHWAY OF CELL-DEATH [J].
CHAO, DT ;
LINETTE, GP ;
BOISE, LH ;
WHITE, LS ;
THOMPSON, CB ;
KORSMEYER, SJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) :821-828
[3]   INDUCTION OF APOPTOSIS BY THE BCL-2 HOMOLOG BAK [J].
CHITTENDEN, T ;
HARRINGTON, EA ;
OCONNOR, R ;
FLEMINGTON, C ;
LUTZ, RJ ;
EVAN, GI ;
GUILD, BC .
NATURE, 1995, 374 (6524) :733-736
[4]   THE BCL-2 GENE FAMILY [J].
CRAIG, RW .
SEMINARS IN CANCER BIOLOGY, 1995, 6 (01) :35-43
[5]  
EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275
[6]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[7]  
ELIOPOULOS AG, 1995, ONCOGENE, V11, P1217
[8]  
FAN SJ, 1994, CANCER RES, V54, P5824
[9]   CLONING OF A BCL-2 HOMOLOG BY INTERACTION WITH ADENOVIRUS E1B 19K [J].
FARROW, SN ;
WHITE, JHM ;
MARTINOU, I ;
RAVEN, T ;
PUN, KT ;
GRINHAM, CJ ;
MARTINOU, JC ;
BROWN, R .
NATURE, 1995, 374 (6524) :731-733
[10]  
FISHER TC, 1993, CANCER RES, V53, P3321